US senators reintroduce legislation aimed at biosimilar ‘patent thickets’
A bipartisan group of four US senators reintroduced the Affordable Prescriptions for Patients Act yesterday, which aims to regulate patent thickets in the so-called “patent dance” of biosimilars litigation.The only patent...To view the full article, register now.
Already a subscriber? Click here to view full article